212 related articles for article (PubMed ID: 12368312)
1. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.
Kimura K; Kakimi K; Wieland S; Guidotti LG; Chisari FV
J Virol; 2002 Nov; 76(21):10702-7. PubMed ID: 12368312
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice.
Cavanaugh VJ; Guidotti LG; Chisari FV
J Virol; 1997 Apr; 71(4):3236-43. PubMed ID: 9060687
[TBL] [Abstract][Full Text] [Related]
3. Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
Kakimi K; Guidotti LG; Koezuka Y; Chisari FV
J Exp Med; 2000 Oct; 192(7):921-30. PubMed ID: 11015434
[TBL] [Abstract][Full Text] [Related]
4. Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice.
Kimura K; Kakimi K; Wieland S; Guidotti LG; Chisari FV
J Immunol; 2002 Nov; 169(9):5188-95. PubMed ID: 12391236
[TBL] [Abstract][Full Text] [Related]
5. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice.
Guidotti LG; Morris A; Mendez H; Koch R; Silverman RH; Williams BR; Chisari FV
J Virol; 2002 Mar; 76(6):2617-21. PubMed ID: 11861827
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures.
Pasquetto V; Wieland SF; Uprichard SL; Tripodi M; Chisari FV
J Virol; 2002 Jun; 76(11):5646-53. PubMed ID: 11991993
[TBL] [Abstract][Full Text] [Related]
7. PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.
Wang XF; Lei Y; Chen M; Chen CB; Ren H; Shi TD
J Viral Hepat; 2013 Apr; 20 Suppl 1():27-39. PubMed ID: 23458522
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice.
Guidotti LG; McClary H; Loudis JM; Chisari FV
J Exp Med; 2000 Apr; 191(7):1247-52. PubMed ID: 10748242
[TBL] [Abstract][Full Text] [Related]
9. CpG oligodeoxynucleotide inhibits HBV replication in a hydrodynamic injection murine model.
Hu W; Huang H; Zhang TY; Mao YY; Wang XJ; Wang SQ
Antivir Ther; 2015; 20(3):289-95. PubMed ID: 25279542
[TBL] [Abstract][Full Text] [Related]
10. Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.
Tsuge M; Uchida T; Hiraga N; Kan H; Makokha GN; Abe-Chayama H; Miki D; Imamura M; Ochi H; Hayes CN; Shimozono R; Iwamura T; Narumi H; Suzuki T; Kainoh M; Taniguchi T; Chayama K
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373196
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-15 suppresses hepatitis B virus replication via IFN-β production in a C57BL/6 mouse model.
Yin W; Xu L; Sun R; Wei H; Tian Z
Liver Int; 2012 Sep; 32(8):1306-14. PubMed ID: 22380514
[TBL] [Abstract][Full Text] [Related]
12. 5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice.
Ebert G; Poeck H; Lucifora J; Baschuk N; Esser K; Esposito I; Hartmann G; Protzer U
Gastroenterology; 2011 Aug; 141(2):696-706, 706.e1-3. PubMed ID: 21684282
[TBL] [Abstract][Full Text] [Related]
13. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver.
Guidotti LG; Borrow P; Hobbs MV; Matzke B; Gresser I; Oldstone MB; Chisari FV
Proc Natl Acad Sci U S A; 1996 May; 93(10):4589-94. PubMed ID: 8643448
[TBL] [Abstract][Full Text] [Related]
14. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.
Lutgehetmann M; Volzt T; Quaas A; Zankel M; Fischer C; Dandri M; Petersen J
Antivir Ther; 2008; 13(1):57-66. PubMed ID: 18389899
[TBL] [Abstract][Full Text] [Related]
15. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
Hagelstein J; Kist A; Stremmel W; Galle PR
Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice.
Wieland SF; Guidotti LG; Chisari FV
J Virol; 2000 May; 74(9):4165-73. PubMed ID: 10756029
[TBL] [Abstract][Full Text] [Related]
17. Effects of oxymatrine on the serum levels of T helper cell 1 and 2 cytokines and the expression of the S gene in hepatitis B virus S gene transgenic mice: a study on the anti-hepatitis B virus mechanism of oxymatrine.
Dong Y; Xi H; Yu Y; Wang Q; Jiang K; Li L
J Gastroenterol Hepatol; 2002 Dec; 17(12):1299-306. PubMed ID: 12423275
[TBL] [Abstract][Full Text] [Related]
18. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.
Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T
Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689
[TBL] [Abstract][Full Text] [Related]
19. APOBEC and iNOS are not the main intracellular effectors of IFN-gamma-mediated inactivation of Hepatitis B virus replication.
Proto S; Taylor JA; Chokshi S; Navaratnam N; Naoumov NV
Antiviral Res; 2008 Jun; 78(3):260-7. PubMed ID: 18313151
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
Klumpp K; Shimada T; Allweiss L; Volz T; Lütgehetmann M; Hartman G; Flores OA; Lam AM; Dandri M
Gastroenterology; 2018 Feb; 154(3):652-662.e8. PubMed ID: 29079518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
